{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T19:40:04Z","timestamp":1795290004979,"version":"4.10.3"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biopha.2024.116899","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T19:39:15Z","timestamp":1718653155000},"page":"116899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease"],"prefix":"10.1016","volume":"177","author":[{"given":"Zahraa","family":"Alkhazaali-Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Sahab-Negah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Boroumand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil","family":"Tavakol-Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116899_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/dmm.030205","article-title":"Neurodegenerative disease: models, mechanisms, and a new hope","volume":"10","author":"Gitler","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.biopha.2024.116899_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-8794-7-26","article-title":"Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-\u03b2","volume":"7","author":"De Felice","year":"2014","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.biopha.2024.116899_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","article-title":"The role of microRNAs in neurodegenerative diseases: a review","volume":"39","author":"Li","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.biopha.2024.116899_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/539179a","article-title":"Neurodegenerative diseases","volume":"539","author":"Heemels","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116899_bib5","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1007\/s12035-015-9205-3","article-title":"Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders?","volume":"53","author":"Ettle","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.116899_bib7","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation\u2014an interesting interplay in Parkinson\u2019s disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3389\/fphar.2019.01555","article-title":"MiR-124 and the underlying therapeutic promise of neurodegenerative disorders","volume":"10","author":"Han","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116899_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/SHK.0000000000000604","article-title":"MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response","volume":"46","author":"Essandoh","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2024.116899_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.116899_bib12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.116899_bib13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/1570159X17666191113101629","article-title":"The potential role of dysfunctions in neuron-microglia communication in the pathogenesis of brain disorders","volume":"18","author":"Chamera","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2024.116899_bib15","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s12035-016-9787-4","article-title":"Kurkowska-Jastrz\u0119bska, Analysis of the role of CX3CL1 (Fractalkine) and its receptor CX3CR1 in traumatic brain and spinal cord injury: insight into recent advances in actions of neurochemokine agents","volume":"54","author":"Poniatowski","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jnr.10645","article-title":"Fractalkine protein localization and gene expression in mouse brain","volume":"73","author":"Tarozzo","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2024.116899_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cns.13982","article-title":"Brain energy metabolism: astrocytes in neurodegenerative diseases","volume":"29","author":"Chen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2024.116899_bib18","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","article-title":"Cholesterol and matrisome pathways dysregulated in astrocytes and microglia","volume":"185","author":"Julia","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116899_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/dneu.22867","article-title":"Oligodendrocytes and myelin: active players in neurodegenerative brains?","volume":"82","author":"Chen","year":"2022","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110158","article-title":"TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease","volume":"37","author":"Lee","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.116899_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2024.116899_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/bmm-2016-0242","article-title":"miRNAs as biomarkers of neurodegenerative disorders","volume":"11","author":"Viswambharan","year":"2017","journal-title":"Biomark. Med."},{"key":"10.1016\/j.biopha.2024.116899_bib23","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s12035-018-1203-9","article-title":"Growth factors and neuroglobin in astrocyte protection against neurodegeneration and oxidative stress","volume":"56","author":"Cabezas","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib24","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/sj.onc.1209912","article-title":"miRNAs and apoptosis: RNAs to die for","volume":"25","author":"Jovanovic","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2024.116899_bib25","article-title":"microRNAs in neurodegeneration: current findings and potential impacts","volume":"8","author":"Sharma","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis. Park."},{"key":"10.1016\/j.biopha.2024.116899_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fphys.2019.00227","article-title":"Emerging roles of miRNAs in brain development and perinatal brain injury","volume":"10","author":"Cho","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2024.116899_bib27","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2024.116899_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116899_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","article-title":"The Microprocessor complex mediates the genesis of microRNAs","volume":"432","author":"Gregory","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116899_bib30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1126\/science.1178705","article-title":"A high-resolution structure of the pre-microRNA nuclear export machinery","volume":"326","author":"Okada","year":"2009","journal-title":"Sci. (80-. )"},{"key":"10.1016\/j.biopha.2024.116899_bib31","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1093\/nar\/gkh824","article-title":"Structural requirements for pre-microRNA binding and nuclear export by Exportin 5","volume":"32","author":"Zeng","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.116899_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/genes13030425","article-title":"Role of miRNAs in neurodegeneration: from disease cause to tools of biomarker discovery and therapeutics","volume":"13","author":"Roy","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2024.116899_bib33","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.3390\/ijms24043443","article-title":"The impact of dysregulated microRNA biogenesis machinery and microRNA sorting on neurodegenerative diseases","volume":"24","author":"Weng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.bbagrm.2014.04.019","article-title":"Structure and function of preQ1 riboswitches","volume":"1839","author":"Eichhorn","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Gene Regul. Mech."},{"key":"10.1016\/j.biopha.2024.116899_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","article-title":"MicroRNAs in neurodegenerative diseases and their therapeutic potential","volume":"133","author":"Junn","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116899_bib36","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1042\/BCJ20160759","article-title":"Molecular mechanisms of Dicer: endonuclease and enzymatic activity","volume":"474","author":"Song","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2024.116899_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.214","article-title":"Dicer and microRNAs protect adult dopamine neurons","volume":"8","author":"Chmielarz","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib38","article-title":"miRNA signature in CSF from patients with primary progressive","volume":"10","author":"Mu\u00f1oz-San Mart\u00edn","year":"2023","journal-title":"Mult. Scler., Neurol. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116899_bib39","first-page":"2276","article-title":"miRNAs as Valuable Diagnostic Biomarkers in Patients with Multiple Sclerosis","volume":"2766","author":"Saeidi","year":"2023","journal-title":"J. Issn."},{"key":"10.1016\/j.biopha.2024.116899_bib40","doi-asserted-by":"crossref","unstructured":"M. Abolghasemi, S.A. Ashrafi, M. Asadi, D. Shanehbandi, S.S. Etehad, E. Poursaei, S.A. Nejadghaderi, S. Shaafi, Altered miR-10, miR-24a, miR-124, and miR-21 Expression in Peripheral Blood Mononuclear Cells of Patients with Multiple Sclerosis, (2022).","DOI":"10.21203\/rs.3.rs-1490169\/v1"},{"key":"10.1016\/j.biopha.2024.116899_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/nsn.nsn_218_22","article-title":"Investigation of miR-146a expression profiles in fecal samples of patients with multiple sclerosis for early diagnosis and treatment","volume":"40","author":"Unlu","year":"2023","journal-title":"Neurol. Sci. Neurophysiol."},{"key":"10.1016\/j.biopha.2024.116899_bib42","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/biom13050865","article-title":"Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson\u2019s Disease","volume":"13","author":"Citterio","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2024.116899_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2024.116899_bib44","doi-asserted-by":"crossref","first-page":"17455","DOI":"10.18632\/oncotarget.24736","article-title":"miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson\u2019s disease","volume":"9","author":"Dos Santos","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116899_bib45","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41598-022-05227-6","article-title":"Early downregulation of hsa-miR-144-3p in serum from drug-na\u00efve Parkinson\u2019s disease patients","volume":"12","author":"Zago","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116899_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.941","article-title":"Identification of aberrant circulating mi RNA s in Parkinson\u2019s disease plasma samples","volume":"8","author":"Chen","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.biopha.2024.116899_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0121-4","article-title":"miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)","volume":"11","author":"Kim","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2024.116899_bib48","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/acschemneuro.8b00460","article-title":"Altered expression levels of microRNA-132 and Nurr1 in peripheral blood of Parkinson\u2019s disease: potential disease biomarkers","volume":"10","author":"Yang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib49","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/ijms21031070","article-title":"Local and systemic humoral response to autologous lineage-negative cells intrathecal administration in ALS patients","volume":"21","author":"Baumert","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2012.08.015","article-title":"Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis","volume":"49","author":"Russell","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib51","first-page":"1","article-title":"Acupuncture ameliorates neuronal cell death, inflammation, and ferroptosis and downregulated miR-23a-3p after intracerebral hemorrhage in rats","author":"Kong","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-015-0161-7","article-title":"Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis","volume":"8","author":"Takahashi","year":"2015","journal-title":"Mol. Brain."},{"key":"10.1016\/j.biopha.2024.116899_bib53","first-page":"365","article-title":"microRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)","volume":"3","author":"Alexandrov","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116899_bib54","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.3390\/ijms21145078","article-title":"Vesicular transport of encapsulated microRNA between glial and neuronal cells","volume":"21","author":"Lukiw","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib55","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.bbadis.2019.06.006","article-title":"Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer\u2019s disease","volume":"1865","author":"Kumar","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib56","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.3233\/JAD-190583","article-title":"A new discovery of MicroRNA-455-3p in Alzheimer\u2019s disease","volume":"72","author":"Kumar","year":"2019","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib57","doi-asserted-by":"crossref","first-page":"30105","DOI":"10.3390\/ijms161226223","article-title":"MicroRNA (miRNA) signaling in the human CNS in sporadic Alzheimer\u2019s disease (AD)-novel and unique pathological features","volume":"16","author":"Zhao","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnmol.2020.00090","article-title":"MicroRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases","volume":"13","author":"Fan","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","article-title":"Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer\u2019s disease (AD) and in primary human neuronal-glial (HNG) cells","volume":"50","author":"Zhao","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2021.100041","article-title":"Diagnostic biomarkers in Alzheimer\u2019s disease","volume":"5","author":"Andersen","year":"2021","journal-title":"Biomark. Neuropsychiatry"},{"key":"10.1016\/j.biopha.2024.116899_bib61","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2024.116899_bib62","doi-asserted-by":"crossref","first-page":"a006239","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2024.116899_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.biopha.2024.116899_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2006-9S311","article-title":"Synaptic remodeling during aging and in Alzheimer\u2019s disease","volume":"9","author":"Masliah","year":"2006","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0197-4580(03)00084-8","article-title":"Hippocampus and entorhinal cortex in mild cognitive impairment and early AD","volume":"25","author":"Pennanen","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2024.116899_bib66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/neur.1996.0056","article-title":"Structural correlates of cognition in dementia: quantification and assessment of synapse change","volume":"5","author":"DeKosky","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.biopha.2024.116899_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-018-0641-y","article-title":"Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer\u2019s disease and cerebrovascular disease pathologies","volume":"6","author":"Katsumata","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biopha.2024.116899_bib68","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/emmm.201100995","article-title":"Cholinergic-associated loss of hnRNP-A\/B in Alzheimer\u2019s disease impairs cortical splicing and cognitive function in mice","volume":"4","author":"Berson","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2024.116899_bib69","first-page":"2711","article-title":"miR\u2011133b is a potential diagnostic biomarker for Alzheimer\u2019s disease and has a neuroprotective role","volume":"18","author":"Yang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2024.116899_bib70","first-page":"24","article-title":"Circulating microRNAs in Alzheimer\u2019s disease: the search for novel biomarkers","volume":"6","author":"Dorval","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib71","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease","volume":"26","author":"Kumar","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2024.116899_bib72","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","article-title":"Micro RNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease","volume":"33","author":"Banzhaf-Strathmann","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2024.116899_bib73","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3233\/JAD-170156","article-title":"Identification of circulating miR-125b as a potential biomarker of Alzheimer\u2019s disease in APP\/PS1 transgenic mouse","volume":"59","author":"Hong","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib74","first-page":"1","article-title":"Dysregulation and diagnostic potential of microRNA in Alzheimer\u2019s disease","volume":"49","author":"Pan","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib75","article-title":"The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer\u2019s disease","volume":"1868","author":"Callens","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.biopha.2024.116899_bib76","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.5620-07.2008","article-title":"Lack of pathology in a triple transgenic mouse model of Alzheimer\u2019s disease after overexpression of the anti-apoptotic protein Bcl-2","volume":"28","author":"Rohn","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib77","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbrc.2016.08.037","article-title":"miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer\u2019s disease","volume":"478","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.116899_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JAD-160203","article-title":"MicroRNAs as therapeutic targets for Alzheimer\u2019s disease","volume":"53","author":"Di Meco","year":"2016","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/JMN:23:1-2:105","article-title":"Bace 1: The \u03b2-secretase enzyme in alzheimer\u2019s disease","volume":"23","author":"Vassar","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib80","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2020-0064","article-title":"MicroRNA-149 is downregulated in Alzheimer\u2019s disease and inhibits \u03b2-amyloid accumulation and ameliorates neuronal viability through targeting BACE1","volume":"44","author":"Du","year":"2021","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116899_bib81","first-page":"3","article-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018","journal-title":"Exon Publ."},{"key":"10.1016\/j.biopha.2024.116899_bib82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2024.116899_bib83","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson\u2019s disease mutations accelerate \u03b1-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116899_bib84","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archneurol.2010.194","article-title":"Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study","volume":"67","author":"Alcalay","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2024.116899_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2024.116899_bib86","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.3390\/ijms20225649","article-title":"Role of MicroRNAs in Parkinson\u2019s disease","volume":"20","author":"Goh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib87","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/mds.27935","article-title":"Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson\u2019s disease","volume":"35","author":"Cressatti","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2024.116899_bib88","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116899_bib89","first-page":"4179","article-title":"Overexpression of miR-153 promotes oxidative stress in MPP+-induced PD model by negatively regulating the Nrf2\/HO-1 signaling pathway","volume":"11","author":"Zhu","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2024.116899_bib90","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.biopha.2024.116899_bib91","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1038\/s41598-017-03887-3","article-title":"Downregulation of blood serum microRNA 29 family in patients with Parkinson\u2019s disease","volume":"7","author":"Bai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116899_bib92","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/stem.2233","article-title":"MiR-375 is essential for human spinal motor neuron development and may be involved in motor neuron degeneration","volume":"34","author":"Bhinge","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2024.116899_bib93","doi-asserted-by":"crossref","first-page":"672","DOI":"10.18632\/aging.102649","article-title":"Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson\u2019s disease by inhibiting SP1","volume":"12","author":"Cai","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2024.116899_bib94","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/jnr.21695","article-title":"Transcription factor Sp1 dysregulation in Alzheimer\u2019s disease","volume":"86","author":"Citron","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2024.116899_bib95","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s11011-020-00546-x","article-title":"MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax","volume":"35","author":"Yang","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib96","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.cdd.4401975","article-title":"Proapoptotic multidomain Bcl-2\/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities","volume":"13","author":"Reed","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2024.116899_bib97","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1013728012048","article-title":"Alteration of the Bcl-2: Bax ratio in the placenta as pregnancy proceeds","volume":"33","author":"De Falco","year":"2001","journal-title":"Histochem. J."},{"key":"10.1016\/j.biopha.2024.116899_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104839","article-title":"Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients","author":"Cantoni","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.biopha.2024.116899_bib99","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","volume":"5","author":"Orton","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2024.116899_bib100","doi-asserted-by":"crossref","first-page":"1199313","DOI":"10.3389\/fnmol.2023.1199313","article-title":"Remyelination in multiple sclerosis from the miRNA perspective","volume":"16","author":"Maciak","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib101","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.it.2005.07.004","article-title":"The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms","volume":"26","author":"Engelhardt","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2024.116899_bib102","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/1352458515613641","article-title":"Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing\u2013remitting multiple sclerosis","volume":"22","author":"Ahlbrecht","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.biopha.2024.116899_bib103","first-page":"19","article-title":"Biomarkers of multiple sclerosis: current findings","author":"Harris","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib104","doi-asserted-by":"crossref","first-page":"705","DOI":"10.14336\/AD.2016.0320","article-title":"MicroRNA-181c exacerbates brain injury in acute ischemic stroke","volume":"7","author":"Ma","year":"2016","journal-title":"Aging Dis."},{"key":"10.1016\/j.biopha.2024.116899_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-211","article-title":"The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor","volume":"9","author":"Zhang","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116899_bib106","article-title":"Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study","volume":"6","author":"Kramer","year":"2019","journal-title":"Neurol. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116899_bib107","article-title":"Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis","volume":"3","author":"Bergman","year":"2016","journal-title":"Neurol. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116899_bib108","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.23967","article-title":"miR-155 as a multiple sclerosis\u2013relevant regulator of myeloid cell polarization","volume":"74","author":"Moore","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2024.116899_bib109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cytogfr.2011.05.002","article-title":"Role of microRNA-155 in autoimmunity","volume":"22","author":"Leng","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2024.116899_bib110","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.3390\/ijms22094332","article-title":"miR-155 as an important regulator of multiple sclerosis pathogenesis. A review","volume":"22","author":"Maciak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib111","first-page":"1","article-title":"Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a\/b in patients with multiple sclerosis and active lesions","volume":"16","author":"Mart\u00edn","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116899_bib112","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/glia.23576","article-title":"miR-223 promotes regenerative myeloid cell phenotype and function in the demyelinated central nervous system","volume":"67","author":"Galloway","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2024.116899_bib113","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/glia.23819","article-title":"In vivo silencing of mir-125a-3p promotes myelin repair in models of white matter demyelination","volume":"68","author":"Marangon","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2024.116899_bib114","doi-asserted-by":"crossref","first-page":"34503","DOI":"10.1038\/srep34503","article-title":"MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis","volume":"6","author":"Lecca","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116899_bib115","doi-asserted-by":"crossref","first-page":"1055313","DOI":"10.3389\/fgene.2022.1055313","article-title":"Analysis of miRNA rare variants in amyotrophic lateral sclerosis and in silico prediction of their biological effects","volume":"13","author":"Brusati","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2024.116899_bib116","first-page":"1","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2024.116899_bib117","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2024.116899_bib118","article-title":"An Overview of MicroRNAs as Biomarkers of ALS","volume":"10","author":"Joilin","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.biopha.2024.116899_bib119","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s12035-017-0537-z","article-title":"MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis","volume":"55","author":"Rinchetti","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.855096","article-title":"MicroRNA alterations in chronic traumatic encephalopathy and amyotrophic lateral sclerosis","volume":"16","author":"Alvia","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089065","article-title":"MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis","volume":"9","author":"Toivonen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116899_bib122","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.3390\/ijms22116128","article-title":"Overexpression of miR-124 in motor neurons plays a key role in ALS pathological processes","volume":"22","author":"Vaz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib123","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","article-title":"Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis","volume":"24","author":"Magen","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib124","first-page":"4207","article-title":"Downregulated glia interplay and increased miRNA-155 as promising markers to track ALS at an early stage","volume":"55","author":"Cunha","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5582\/irdr.2017.01091","article-title":"Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients","volume":"7","author":"Xu","year":"2018","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.biopha.2024.116899_bib126","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5264","article-title":"Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology","volume":"11","author":"Reichenstein","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2024.116899_bib127","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1128\/MCB.20.10.3345-3354.2000","article-title":"TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins","volume":"20","author":"Yang","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2024.116899_bib128","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1073\/pnas.1112427109","article-title":"TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes","volume":"109","author":"Kawahara","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib129","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2024.116899_bib130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"neuron"},{"key":"10.1016\/j.biopha.2024.116899_bib131","doi-asserted-by":"crossref","first-page":"1131758","DOI":"10.3389\/fnins.2023.1131758","article-title":"Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications","volume":"17","author":"Koike","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib132","article-title":"Systematic review and meta-analysis on microRNAs in Amyotrophic Lateral Sclerosis","author":"Liu","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2024.116899_bib133","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/ijms19051534","article-title":"Skeletal muscle microRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis","volume":"19","author":"Di Pietro","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib134","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5414\/NP301233","article-title":"MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients","volume":"39","author":"Pegoraro","year":"2020","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.biopha.2024.116899_bib135","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/676575","article-title":"Noncoding RNAs, emerging regulators of skeletal muscle development and diseases","volume":"2015","author":"Nie","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2024.116899_bib136","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1181046","article-title":"MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice","volume":"326","author":"Williams","year":"2009","journal-title":"Sci. (80-. )"},{"key":"10.1016\/j.biopha.2024.116899_bib137","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.24304","article-title":"Targeting mi R-155 restores abnormal microglia and attenuates disease in SOD 1 mice","volume":"77","author":"Butovsky","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2024.116899_bib138","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/cells11071186","article-title":"Neurotoxic astrocytes directly converted from sporadic and familial ALS patient fibroblasts reveal signature diversities and miR-146a theragnostic potential in specific subtypes","volume":"11","author":"Gomes","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116899_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-6-26","article-title":"Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels","volume":"6","author":"Campos-Melo","year":"2013","journal-title":"Mol. Brain."},{"key":"10.1016\/j.biopha.2024.116899_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8884642","article-title":"Diagnostic and therapeutic potential of exosomal microRNAs for neurodegenerative diseases","volume":"2021","author":"He","year":"2021","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2024.116899_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117447","article-title":"Free and hydrogel encapsulated exosome-based therapies in regenerative medicine","volume":"249","author":"Akbari","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib142","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1039\/C7NR00352H","article-title":"Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration","volume":"9","author":"Liu","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.116899_bib143","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trci.2015.06.007","article-title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase 1 clinical trial","volume":"1","author":"Kim","year":"2015","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.biopha.2024.116899_bib144","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2024.116899_bib145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gt.2009.23","article-title":"AAV for pain: steps towards clinical translation","volume":"16","author":"Beutler","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2024.116899_bib146","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116899_bib147","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jgm.2810","article-title":"Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells","volume":"16","author":"Ekin","year":"2014","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2024.116899_bib148","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nmat4497","article-title":"Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment","volume":"15","author":"Conde","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2024.116899_bib149","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1021\/acs.biomac.6b00754","article-title":"Fructose-coated nanodiamonds: promising platforms for treatment of human breast cancer","volume":"17","author":"Zhao","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biopha.2024.116899_bib150","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1002\/anie.201504913","article-title":"Single-vehicular delivery of antagomir and small molecules to inhibit miR-122 function in hepatocellular carcinoma cells by using \u201csmart\u201d mesoporous silica nanoparticles","volume":"54","author":"Yu","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.116899_bib151","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt0713-577","article-title":"First microRNA mimic enters clinic","volume":"31","author":"Austin","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116899_bib152","doi-asserted-by":"crossref","first-page":"851","DOI":"10.15252\/emmm.201100899","article-title":"Development of micro RNA therapeutics is coming of age","volume":"6","author":"Van Rooij","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2024.116899_bib153","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.116899_bib154","article-title":"Therapeutic implication of miRNA in human disease","author":"Walayat","year":"2018","journal-title":"Antisense Ther."},{"key":"10.1016\/j.biopha.2024.116899_bib155","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/gt.2011.100","article-title":"Chemical modification and design of anti-miRNA oligonucleotides","volume":"18","author":"Lennox","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2024.116899_bib156","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","article-title":"Therapeutic targeting of microRNAs: current status and future challenges","volume":"13","author":"Li","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.116899_bib157","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-60761-863-8_3","article-title":"The principles of MiRNA-masking antisense oligonucleotides technology","author":"Wang","year":"2011","journal-title":"Micro Cancer Methods Protoc."},{"key":"10.1016\/j.biopha.2024.116899_bib158","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1261\/rna.2414110","article-title":"MicroRNA sponges: progress and possibilities","volume":"16","author":"Ebert","year":"2010","journal-title":"Rna"},{"key":"10.1016\/j.biopha.2024.116899_bib159","first-page":"147","article-title":"Bottleneck limitations for microRNA-based therapeutics from bench to the bedside","volume":"70","author":"Chen","year":"2015","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib160","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.biopha.2024.116899_bib161","first-page":"1","article-title":"Potential Roles of MicroRNAs in Neurodegenerative Diseases","volume":"14","author":"Medinenur","year":"2024","journal-title":"Experimed"},{"key":"10.1016\/j.biopha.2024.116899_bib162","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/genes13061034","article-title":"Differentially expressed miRNAs in age-related neurodegenerative diseases: a meta-analysis","volume":"13","author":"Noronha","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.biopha.2024.116899_bib163","doi-asserted-by":"crossref","first-page":"16259","DOI":"10.3390\/ijms242216259","article-title":"Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer\u2019s Disease","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116899_bib164","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1007\/s12035-016-0088-8","article-title":"Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer\u2019s disease: potential and limitations","volume":"54","author":"Cos\u00edn-Tom\u00e1s","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.705989","article-title":"Reduced levels of miR-342-5p in plasma are associated with worse cognitive evolution in patients with mild Alzheimer\u2019s disease","volume":"13","author":"Dakterzada","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib166","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-023-02816-8","article-title":"Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study","volume":"20","author":"Gonzalez-Martinez","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116899_bib167","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12031-014-0290-y","article-title":"Increased expression of microRNA-29a in ALS mice: functional analysis of its inhibition","volume":"53","author":"Nolan","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib168","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ebiom.2018.11.067","article-title":"Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS","volume":"40","author":"Varcianna","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2024.116899_bib169","first-page":"1","article-title":"A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer\u2019s Disease","author":"Mishra","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib170","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fnins.2020.00564","article-title":"Therapeutic effects of transplanted exosomes containing miR-29b to a rat model of Alzheimer\u2019s disease","volume":"14","author":"Jahangard","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib171","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1039\/D1NR06939J","article-title":"Overcoming barriers in non-viral gene delivery for neurological applications","volume":"14","author":"Tasset","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.116899_bib172","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/pharmaceutics15041216","article-title":"Small Extracellular Vesicles\u2019 miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases","volume":"15","author":"Lim","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.116899_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116691","article-title":"Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders","volume":"175","author":"Naimi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116899_bib174","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1007\/s13346-023-01362-3","article-title":"Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy","volume":"13","author":"Dogbey","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2024.116899_bib175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/epi.12267","article-title":"Antagomirs and micro RNA in status epilepticus","volume":"54","author":"Henshall","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2024.116899_bib176","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/molecules23071825","article-title":"Delivery of miRNA-targeted oligonucleotides in the rat striatum by magnetofection with Neuromag\u00ae","volume":"23","author":"Titze de Almeida","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116899_bib177","series-title":"in: Nov. Psychoact. Subst.","first-page":"179","article-title":"1-Benzylpiperazine and other Piperazine-based Derivatives","author":"Gee","year":"2013"},{"key":"10.1016\/j.biopha.2024.116899_bib178","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bioorg.2018.12.017","article-title":"Biphenyl-3-oxo-1, 2, 4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory","volume":"85","author":"Tripathi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116899_bib179","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmech.2018.11.049","article-title":"Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory","volume":"163","author":"Srivastava","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116899_bib180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/diseases11030089","article-title":"WNT-\u03b2 catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective","volume":"11","author":"Ramakrishna","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.biopha.2024.116899_bib181","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s12035-020-01945-y","article-title":"Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer\u2019s disease","volume":"57","author":"Rai","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116899_bib182","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnagi.2018.00192","article-title":"Commentary: Mild endoplasmic reticulum stress ameliorates lpopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization","volume":"10","author":"Rai","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2024.116899_bib183","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2230-973X.167646","article-title":"An overview of viral and nonviral delivery systems for microRNA","volume":"5","author":"Yang","year":"2015","journal-title":"Int. J. Pharm. Investig."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:13:45Z","timestamp":1782173625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224007832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":183,"alternative-id":["S0753332224007832"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116899","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116899"}}